U.K. FreeDM2 randomized controlled trial: At four months, people using Libre technology had a 0.6% greater reduction in HbA1c and 2.5 more hours a day in the healthy range vs. …
Copyright MatchingDonors.com©️ 2025 All rights reserved.
U.K. FreeDM2 randomized controlled trial: At four months, people using Libre technology had a 0.6% greater reduction in HbA1c and 2.5 more hours a day in the healthy range vs. …
Image Credit: freepik Lately, you have been experiencing a bad mood with low energy, cravings, and even mood swings. But what’s really going on? Blood sugar might be a major …
ABSTRACT Objectives: This analysis evaluated changes in glucose management indicator (GMI) at 12 months from baseline hemoglobin A1c (HbA1c)—which are both used interchangeably in the Healthcare Effectiveness Data and Information …
LAS VEGAS, Dec. 16, 2025 /CNW/ — Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cell-based therapies for diabetes and age-related disorders, …
The most consistent benefits for adults with type 1 diabetes (T1D) can be seen with a combination of a low-carbohydrate diet, education, carbohydrate counting, and modern diabetes technology, such as …
Bahari, N. I. et al. Issues and challenges in the primary prevention of type 2 diabetes mellitus: A systematic review. J. Prev. 44, 105–125 (2023). Article Google Scholar Roman, S. …
NASHVILLE, Tenn. (Ivanhoe Newswire) — The number of adults living with diabetes worldwide has surpassed 800 million, and the World Health Organization calls Type 2 diabetes an epidemic. But new …
PLEASANTON, Calif., Nov. 4, 2025 /PRNewswire/ — Aqua Medical, a company advancing Endoscopic Metabolic Restoration for type 2 diabetes, today announced that the U.S. Food and Drug Administration (FDA) has …
Mobile, Alabama (WALA) – USA Health is currently providing Histotripy, a non-invasive medical procedure that breaks down Gulf tumors, to patients in the Gulf Coast and surrounding areas. This morning, …
Abbott's Libre® Technology is the first continuous glucose monitor associated with reduced hospitalizations for cardiac complications in diabetic patients New data reveal a 78% reduction in cardiovascular disease-related hospitalizations in …
Today’s Diabetes News, your ultimate destination for up-to-date and insightful information on diabetes, health tips, and living a fulfilling life with diabetes. Our mission is to empower and support individuals with diabetes, their loved ones, and the wider community by providing reliable, relevant, and engaging content that fosters a healthier and happier life.
Copyright MatchingDonors.com©️ 2025 All rights reserved.
tag -->